These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 8889989

  • 1. Preventing allograft rejection with CTLA4IG: effect of donor-specific transfusion route or timing.
    Bolling SF, Lin H, Wei RQ, Turka LA.
    J Heart Lung Transplant; 1996 Sep; 15(9):928-35. PubMed ID: 8889989
    [Abstract] [Full Text] [Related]

  • 2. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
    Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1997 Aug 15; 159(4):1711-7. PubMed ID: 9257832
    [Abstract] [Full Text] [Related]

  • 3. The time course of CTLAIg effect on cardiac allograft rejection.
    Bolling SF, Lin H, Turka LA.
    J Surg Res; 1996 Jun 15; 63(1):320-3. PubMed ID: 8661218
    [Abstract] [Full Text] [Related]

  • 4. CD28 blockade alters cytokine mRNA profiles in cardiac transplantation.
    Lin H, Wei RQ, Goodman RE, Bolling SF.
    Surgery; 1997 Aug 15; 122(2):129-37. PubMed ID: 9288115
    [Abstract] [Full Text] [Related]

  • 5. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation.
    Séveno C, Coulon F, Haspot F, Mérieau E, Renaudin K, Martinet B, Vanhove B.
    Xenotransplantation; 2007 Jan 15; 14(1):25-33. PubMed ID: 17214702
    [Abstract] [Full Text] [Related]

  • 6. The effect of combination cyclosporine and CTLA4-Ig therapy on cardiac allograft survival.
    Bolling SF, Lin H, Wei RQ, Linsley P, Turka LA.
    J Surg Res; 1994 Jul 15; 57(1):60-4. PubMed ID: 8041150
    [Abstract] [Full Text] [Related]

  • 7. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.
    Am J Pathol; 2001 Mar 15; 158(3):977-86. PubMed ID: 11238045
    [Abstract] [Full Text] [Related]

  • 8. Comparative strategies to induce long-term graft acceptance in fully allogeneic renal versus cardiac allograft models by CD28-B7 T cell costimulatory blockade: role of thymus and spleen.
    Schaub M, Stadlbauer TH, Chandraker A, Vella JP, Turka LA, Sayegh MH.
    J Am Soc Nephrol; 1998 May 15; 9(5):891-8. PubMed ID: 9596088
    [Abstract] [Full Text] [Related]

  • 9. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

  • 10. Blockade of CD28/B7-2 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts: suppression of helper T cell type1-dominated immune response.
    Tikkanen JM, Lemström KB, Koskinen PK.
    Am J Respir Crit Care Med; 2002 Mar 01; 165(5):724-9. PubMed ID: 11874822
    [Abstract] [Full Text] [Related]

  • 11. CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.
    Baliga P, Chavin KD, Qin L, Woodward J, Lin J, Linsley PS, Bromberg JS.
    Transplantation; 1994 Nov 27; 58(10):1082-90. PubMed ID: 7526493
    [Abstract] [Full Text] [Related]

  • 12. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH, Zheng XG, Magee C, Hancock WW, Turka LA.
    Transplantation; 1997 Dec 27; 64(12):1646-50. PubMed ID: 9422396
    [Abstract] [Full Text] [Related]

  • 13. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH, Schaub M, Korom S, Onodera K, Sayegh MH, Kupiec-Weglinski JW.
    Transplantation; 1997 Dec 27; 64(12):1816-22. PubMed ID: 9422425
    [Abstract] [Full Text] [Related]

  • 14. Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion.
    Lin H, Bolling SF, Linsley PS, Wei RQ, Gordon D, Thompson CB, Turka LA.
    J Exp Med; 1993 Nov 01; 178(5):1801-6. PubMed ID: 8228826
    [Abstract] [Full Text] [Related]

  • 15. [Preoperative inoculation of CTLA4Ig combined with allogeneic dendritic cells prolongs rat renal allograft survival in a donor-specific fashion].
    Harada H.
    Hokkaido Igaku Zasshi; 1999 May 01; 74(3):189-98. PubMed ID: 10422563
    [Abstract] [Full Text] [Related]

  • 16. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L, Fujino M, Kimura H, Funeshima N, Kitazawa Y, Harihara Y, Tezuka K, Makuuchi M, Suzuki S, Li XK.
    Transpl Immunol; 2003 May 01; 12(1):41-8. PubMed ID: 14551031
    [Abstract] [Full Text] [Related]

  • 17. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W, Wang Q, Zhang L, Liu Y, Zhang M, Wang C, Wang J, Cao X.
    Transplantation; 2003 Nov 15; 76(9):1351-9. PubMed ID: 14627915
    [Abstract] [Full Text] [Related]

  • 18. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
    Azuma H, Chandraker A, Nadeau K, Hancock WW, Carpenter CB, Tilney NL, Sayegh MH.
    Proc Natl Acad Sci U S A; 1996 Oct 29; 93(22):12439-44. PubMed ID: 8901600
    [Abstract] [Full Text] [Related]

  • 19. Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.
    Russell ME, Hancock WW, Akalin E, Wallace AF, Glysing-Jensen T, Willett TA, Sayegh MH.
    J Clin Invest; 1996 Feb 01; 97(3):833-8. PubMed ID: 8609241
    [Abstract] [Full Text] [Related]

  • 20. Differential effect of CTLA4Ig on murine graft-versus-host disease (GVHD) development: CTLA4Ig prevents both acute and chronic GVHD development but reverses only chronic GVHD.
    Via CS, Rus V, Nguyen P, Linsley P, Gause WC.
    J Immunol; 1996 Nov 01; 157(9):4258-67. PubMed ID: 8892665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.